EOSINOPHILIC ESOPHAGITIS (EOE)
Clinical trials for EOSINOPHILIC ESOPHAGITIS (EOE) explained in plain language.
Never miss a new study
Get alerted when new EOSINOPHILIC ESOPHAGITIS (EOE) trials appear
Sign up with your email to follow new studies for EOSINOPHILIC ESOPHAGITIS (EOE), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Which EoE drug wins? new study pits budesonide against dupilumab
Disease control ENROLLING_BY_INVITATIONThis study compares two treatments for eosinophilic esophagitis (EoE), a condition that causes swelling and scarring in the esophagus. Researchers will give 60 adults either swallowed budesonide (Eohilia) or injected dupilumab (Dupixent) for 12 weeks to see which better improves …
Matched conditions: EOSINOPHILIC ESOPHAGITIS (EOE)
Phase: EARLY_PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 26, 2026 08:20 UTC
-
New drug shows promise for chronic swallowing disorder
Disease control OngoingThis study tests an experimental drug called NSI-8226 (solrikitug) in 184 adults with eosinophilic esophagitis, a condition that causes throat inflammation and trouble swallowing. Participants receive either the drug or a placebo to see if it reduces throat inflammation and impro…
Matched conditions: EOSINOPHILIC ESOPHAGITIS (EOE)
Phase: PHASE2 • Sponsor: Uniquity One (UNI) • Aim: Disease control
Last updated May 19, 2026 11:48 UTC